• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后综合征患者中无糖尿病个体的体成分表型与胰岛素抵抗的相关性:一项横断面、单中心研究。

The Association between Body Composition Phenotype and Insulin Resistance in Post-COVID-19 Syndrome Patients without Diabetes: A Cross-Sectional, Single-Center Study.

机构信息

Heart Failure and Respiratory Distress Clinic, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City 14080, Mexico.

Department of Epidemiological Information Analysis, General Directorate of Epidemiology, Mexico City 01480, Mexico.

出版信息

Nutrients. 2024 Jul 30;16(15):2468. doi: 10.3390/nu16152468.

DOI:10.3390/nu16152468
PMID:39125348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11314085/
Abstract

BACKGROUND

The most frequent body composition alterations in post-COVID-19 syndrome include low muscle mass, dynapenia, sarcopenia, and obesity. These conditions share interconnected pathophysiological mechanisms that exacerbate each other. The relationship between body composition phenotypes and metabolic abnormalities in post-COVID-19 syndrome remains unclear.

OBJECTIVE

To evaluate the association between body composition phenotypes and insulin resistance (IR) and metabolic abnormalities in non-diabetic individuals with post-COVID-19 syndrome.

METHODS

A cross-sectional, single-center study involving 483 subjects with post-COVID-19 syndrome following moderate to severe acute COVID-19 requiring hospitalization. Individuals with diabetes, those who declined to participate, or those who could not be contacted were excluded. Body composition phenotypes were classified as normal weight, dynapenia, sarcopenia, dynapenic obesity, and sarcopenic obesity (SO).

RESULTS

The average age was 52.69 ± 14.75 years; of note, 67.08% were male. The prevalence of body composition phenotypes was as follows: 13.25% were of normal weight, 9.52% had dynapenia, 9.94% had sarcopenia, 43.69% had obesity, 18.84% had dynapenic obesity, and 4.76% had SO. Additionally, 58.18% had IR. Obesity (OR: 2.98, CI95%; 1.64-5.41) and dynapenic obesity (OR: 4.98, CI95%; 1.46-6.88) were associated with IR.

CONCLUSION

The most common body composition phenotypes were obesity, dynapenic obesity, and dynapenia. Furthermore, obesity and dynapenic obesity were associated with IR in post-COVID-19 syndrome.

摘要

背景

新冠病毒病(COVID-19)后最常见的身体成分改变包括肌肉量减少、无力、肌肉减少症和肥胖。这些情况具有相互关联的病理生理机制,会相互加重。新冠病毒病后综合征患者的身体成分表型与代谢异常之间的关系尚不清楚。

目的

评估非糖尿病新冠病毒病后综合征患者的身体成分表型与胰岛素抵抗(IR)和代谢异常之间的关系。

方法

这是一项横断面、单中心研究,共纳入 483 例因中重度急性 COVID-19 需要住院治疗的新冠病毒病后综合征患者。排除患有糖尿病、拒绝参与或无法联系的患者。将身体成分表型分为正常体重、无力、肌肉减少症、无力性肥胖和肌肉减少性肥胖(SO)。

结果

患者的平均年龄为 52.69±14.75 岁,其中 67.08%为男性。身体成分表型的患病率如下:正常体重占 13.25%,无力占 9.52%,肌肉减少症占 9.94%,肥胖占 43.69%,无力性肥胖占 18.84%,SO 占 4.76%。此外,58.18%的患者存在 IR。肥胖(OR:2.98,95%CI:1.64-5.41)和无力性肥胖(OR:4.98,95%CI:1.46-6.88)与 IR 相关。

结论

最常见的身体成分表型是肥胖、无力性肥胖和无力。此外,肥胖和无力性肥胖与新冠病毒病后综合征患者的 IR 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/6052f18665f9/nutrients-16-02468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/e972c90c00b3/nutrients-16-02468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/9338a082a115/nutrients-16-02468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/6052f18665f9/nutrients-16-02468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/e972c90c00b3/nutrients-16-02468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/9338a082a115/nutrients-16-02468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c3b/11314085/6052f18665f9/nutrients-16-02468-g003.jpg

相似文献

1
The Association between Body Composition Phenotype and Insulin Resistance in Post-COVID-19 Syndrome Patients without Diabetes: A Cross-Sectional, Single-Center Study.新冠病毒感染后综合征患者中无糖尿病个体的体成分表型与胰岛素抵抗的相关性:一项横断面、单中心研究。
Nutrients. 2024 Jul 30;16(15):2468. doi: 10.3390/nu16152468.
2
Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function.新冠后综合征住院患者的肌无力和肌少症与肺功能严重下降有关。
J Clin Med. 2023 Oct 11;12(20):6466. doi: 10.3390/jcm12206466.
3
Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections.与中度或重度 COVID-19 感染后 COVID 患者肌少症相关的身体成分和风险因素。
BMC Pulm Med. 2022 Jun 8;22(1):223. doi: 10.1186/s12890-022-02014-x.
4
Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19.动力型肥胖和肌少型肥胖与 COVID-19 并发症风险的关联。
Int J Mol Sci. 2022 Jul 27;23(15):8277. doi: 10.3390/ijms23158277.
5
Worsening Disability and Hospitalization Risk in Sarcopenic Obese and Dynapenic Abdominal Obese: A 5.5 Years Follow-Up Study in Elderly Men and Women.肌少型肥胖与腹型肥胖患者的残疾加重和住院风险增加:一项对老年男女进行的 5.5 年随访研究。
Front Endocrinol (Lausanne). 2020 Jun 30;11:314. doi: 10.3389/fendo.2020.00314. eCollection 2020.
6
Obesity phenotypes are, in part, associated with physical activity in diabetic hemodialysis patients.肥胖表型在一定程度上与糖尿病血液透析患者的身体活动有关。
Int Urol Nephrol. 2022 Jul;54(7):1751-1759. doi: 10.1007/s11255-021-03060-w. Epub 2021 Nov 23.
7
Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5-10 Years in Community-Dwelling Older Adults.社区居住老年人中肌肉减少性肥胖和动力性肥胖与骨密度及5至10年骨折发生率的关联
Calcif Tissue Int. 2016 Jul;99(1):30-42. doi: 10.1007/s00223-016-0123-9. Epub 2016 Mar 4.
8
The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity.肥胖成年女性中与代谢紊乱相关的肌肉力量和肌肉质量下降。
Clin Nutr. 2019 Oct;38(5):2430-2435. doi: 10.1016/j.clnu.2019.01.028. Epub 2019 Feb 10.
9
Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus.1 型糖尿病患者中肌少症和肌无力的流行情况及其相关临床结局。
Nutrients. 2023 Nov 24;15(23):4914. doi: 10.3390/nu15234914.
10
The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.胰岛素抵抗和炎症对消瘦肥胖与身体功能之间关联的影响。
Obesity (Silver Spring). 2012 Oct;20(10):2101-6. doi: 10.1038/oby.2012.20. Epub 2012 Feb 7.

引用本文的文献

1
Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study.墨西哥东北部代谢综合征患者中 COVID-19 疫苗对 SARS-CoV-2 感染、住院和死亡的有效性评估:一项多中心研究
Vaccines (Basel). 2025 Feb 27;13(3):244. doi: 10.3390/vaccines13030244.
2
More comprehensive relationship between eGDR and sarcopenia in China: a nationwide cohort study with national representation.中国估算肾小球滤过率(eGFR)与肌肉减少症之间更全面的关系:一项具有全国代表性的全国性队列研究。
Diabetol Metab Syndr. 2025 Mar 24;17(1):97. doi: 10.1186/s13098-025-01657-0.
3

本文引用的文献

1
Nutritional and Morphofunctional Assessment of Post-ICU Patients with COVID-19 at Hospital Discharge: NutriEcoMuscle Study.COVID-19 后 ICU 患者出院时的营养和形态功能评估:NutriEcoMuscle 研究。
Nutrients. 2024 Mar 19;16(6):886. doi: 10.3390/nu16060886.
2
Long-term outcomes in critically ill patients who survived COVID-19: The NUTRICOVID observational cohort study.COVID-19 幸存者危重症患者的长期结局:NUTRICOVID 观察性队列研究。
Clin Nutr. 2023 Oct;42(10):2029-2035. doi: 10.1016/j.clnu.2023.08.008. Epub 2023 Aug 16.
3
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Accumulated subcutaneous fat in abdomen is associated with long COVID-19 symptoms among non-hospitalized patients: a prospective observational study.
腹部皮下脂肪堆积与非住院患者的新冠长期症状有关:一项前瞻性观察研究。
Front Med (Lausanne). 2024 Oct 14;11:1410559. doi: 10.3389/fmed.2024.1410559. eCollection 2024.
新冠肺炎患者出院后 6 个月的后果:一项队列研究。
Lancet. 2023 Jun 17;401(10393):e21-e33. doi: 10.1016/S0140-6736(23)00810-3. Epub 2023 Jun 12.
4
Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者新发糖尿病风险增加:系统评价和荟萃分析。
Front Public Health. 2023 May 25;11:1170156. doi: 10.3389/fpubh.2023.1170156. eCollection 2023.
5
Sarcopenia and Multisensory Integration Deficit in Post-COVID Syndrome Patients: The Clinical, Ultrasound and Robotic Evaluation Protocol in a Cross-sectional Study.肌少症与新冠后综合征患者的多感觉整合缺陷:一项横断面研究中的临床、超声和机器人评估方案。
Am J Phys Med Rehabil. 2024 Mar 1;103(3):181-187. doi: 10.1097/PHM.0000000000002291. Epub 2023 May 18.
6
Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19: a randomised controlled trial.一项为期 16 周的基于家庭的运动训练计划对严重/危重新冠肺炎幸存者的健康相关生活质量、功能能力和持续症状的影响:一项随机对照试验。
Br J Sports Med. 2023 Oct;57(20):1295-1303. doi: 10.1136/bjsports-2022-106681. Epub 2023 May 10.
7
COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia.老年患者的新冠病毒病:新冠后肌肉减少症评估
Biomedicines. 2023 Feb 28;11(3):733. doi: 10.3390/biomedicines11030733.
8
Gender-Specific Prevalence and Risk Factors of Sarcopenic Obesity in the Korean Elderly Population: A Nationwide Cross-Sectional Study.性别特异性的韩国老年人群体肌少型肥胖患病率及相关因素:一项全国性横断面研究。
Int J Environ Res Public Health. 2023 Jan 9;20(2):1140. doi: 10.3390/ijerph20021140.
9
Reduced muscle strength in patients with long-COVID-19 syndrome is mediated by limb muscle mass.长新冠综合征患者肌肉力量下降是由四肢肌肉质量介导的。
J Appl Physiol (1985). 2023 Jan 1;134(1):50-58. doi: 10.1152/japplphysiol.00599.2022. Epub 2022 Nov 30.
10
Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections.与中度或重度 COVID-19 感染后 COVID 患者肌少症相关的身体成分和风险因素。
BMC Pulm Med. 2022 Jun 8;22(1):223. doi: 10.1186/s12890-022-02014-x.